|Day Low/High||74.72 / 75.68|
|52 Wk Low/High||69.35 / 89.27|
Jim Cramer highlights bank, health-care companies reporting next week and what to watch.
Dividend growers Texas Instruments, Accenture and Medtronic are superior to companies that simply sport high dividend yields, says one portfolio manager.
An attempt to repeal the Affordable Care Act and the brewing policy war between President-elect Donald Trump and the Democrats won't slow these three health sector juggernauts.
Sirius, Medtronic and Carlyle could be money makers in 2017, says Jim Cramer.
Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.
Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.
While most investors fixate on Dow 20,000, breakouts are already happening in the individual stocks.
Here's a look at the 10 best dividend stocks to invest in for potential outperformance in 2017.
Insiders at these companies -- including Medtronic and Medicines -- have been scooping up shares of their own stock lately.
Just like cloud computing drove Amazon, AI should do the same for Big Blue.
As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.
Broadcom released better-than-expected 2016 fourth-quarter results, and its stock on Friday is giving a picture of where the rally could 'broaden to,' says Jim Cramer.
Deutsche Bank downgraded Fitbit to 'hold,' given slower growth in the wearables market.
In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.
Cramer shares his views on taking risk in retail and why some beats are better. TJX, Starbucks and NXP Semi are among the stocks discussed.
President-elect Trump's vague healthcare policy has put the $3 trillion industry on edge.
There are some good ones today, but for different reasons.
Medtronic MDT saw share prices fall sharply Tuesday morning after it reported worse-than-expected earnings for the second quarter of 2017 thanks to slow revenue growth.
In the week ahead, the markets are likely to pull back as the long-term dangers of Trump's victory start to sink in.
Cramer shares his views on takeover talks. NXP Semiconductor, Apple and Citigroup are among the stocks discussed.
But several airline and retail stocks are proving highly volatile.
The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.